(UroToday.com) Despite wide-spread adoption, there is a paucity of data on oncologic outcomes after robot-assisted partial nephrectomy and no predictive models. At the American Urological Association (AUA) 2020 Virtual Meeting, Alessandro Larcher, MD, and colleagues presented results of their study investigating predictors of adverse oncologic outcomes in renal cell carcinoma (RCC) patients treated with robot-assisted partial nephrectomy in a large, multicenter, global analysis.